Intergroup, I.M. (2025) “05 | Revisiting cancer risk associated with the MITF p.e318k variant beyond melanoma: Debora Tonello1, Beatrice Zennaro1, Stefania Pellegrini1, Monica Quaggio2, Luisa Piccin3, Alessio Fabozzi4, Luigi Dall’Olmo2|5, Saveria Tropea5, Maria Chiara Scaini1, Chiara Menin1 | 1Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova; 2Department of Surgery, Oncology and Gastroenterology, Section of Immunology and Oncology, AIDS Reference Center, University of Padova, Padova; 3Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padova; 4Oncology Unit 3, Veneto Institute of Oncology - IOV-IRCCS, Padua; 5Soft-Tissue, Peritoneum, and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy”., Dermatology Reports [Preprint]. doi:10.4081/dr.2025.10747.